Gregory Hartig, MD

Over the past 20 years, Dr. Hartig has functioned as the primary ablative and reconstructive head and neck cancer surgeon at the University of Wisconsin. He currently serves as vice chairman of the Division of Otolaryngology, Head and Neck Surgery and director of the Microvascular Surgery Fellowship. He and Dr. Paul Harari have worked to develop a strong and cohesive team committed to the multidisciplinary management of all head and neck cancer patients. Dr. Hartig’s recent research interests have focused on improving the viability and integrity of HN free flaps and utilizing the extensive UW HNC database to better define the role of selective neck dissection and limited parotid surgery. He is co-leader with Dr. Harari on the Wisconsin Head and Neck SPORE’s Project 2, “Therapeutic combination of CLR1404 with external beam radiation in recurrent head and neck cancer.” He is committed to continue providing fresh HN tumor specimens for expansion of the patient-derived xenograft repository and will actively screen and enroll patients on the phase I clinical trial for recurrent HNC patients to receive CLR1404. He is dedicated to HNC research and training programs and works closely with Drs. Thibeault and Rapraeger to recruit new study themes and investigators to the Developmental Research Program within the Wisconsin HN SPORE.